Historical record - last NADAC publication: 5/22/2024
Product Information
PENICILLAMINE 250 MG CAPSULE is a generic product labeled by Endo USA Inc., priced at $9.2914 per EA under NDC 49884014601. Its NADAC has been published 52 times since May 22, 2024.
Strength
250 mg/1
Manufacturer
Endo USA Inc.NDC
49884014601
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
5/22/2024
Active Ingredients
PENICILLAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA211231On Market Since
1/8/2020
Pharmacological Classes
Price Statistics
The NADAC for PENICILLAMINE 250 MG CAPSULE has been published 52 times since May 22, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.2914 per EA |
|---|---|
| All-time high | $9.2914 (May 14, 2025) |
| All-time low | $9.2914 (May 22, 2024) |
| Median price | $9.2914 |
| Average price | $9.2914 |
| Largest weekly change | 0.0% (May 29, 2024) |
| Weeks tracked | 52 |
| Tracking since | May 22, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PENICILLAMINE 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PENICILLAMINE 250 MG CAPSULE, manufactured by Endo USA Inc., is $9.2914 per EA (NDC 49884014601), effective May 14, 2025.
How has the price of PENICILLAMINE 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PENICILLAMINE 250 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 52 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for PENICILLAMINE 250 MG CAPSULE?
Since May 22, 2024, the NADAC for PENICILLAMINE 250 MG CAPSULE has ranged from a low of $9.2914 (May 22, 2024) to a high of $9.2914 (May 14, 2025), with a median of $9.2914 per EA.
Are there cheaper alternatives to PENICILLAMINE 250 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as PENICILLAMINE 250 MG CAPSULE, but none are currently priced below it.
Who manufactures PENICILLAMINE 250 MG CAPSULE?
PENICILLAMINE 250 MG CAPSULE (NDC 49884014601) is labeled by Endo USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification